• Dissecting P. aeruginosa Resistance: ampC/ampD Mutations and

  2026-05-13

  This study elucidates how specific ampC and ampD mutations drive ceftolozane-tazobactam resistance and imipenem susceptibility shifts in Pseudomonas aeruginosa, using advanced semi-mechanistic PKPD modeling. The findings refine our understanding of adaptive versus acquired resistance and offer a framework for precisely characterizing complex resistance mechanisms in clinical isolates.

• Astrocyte-to-Motoneuron Reprogramming via Ascl1-Myt1l-Pou3f2

  2026-05-13

  The referenced study demonstrates that a four-factor transcriptional cocktail (Ascl1, Myt1l, Pou3f2, Isl1) can directly reprogram spinal astrocytes into motoneuron-like cells. This approach offers a promising alternative to stem cell therapies for spinal cord injury, advancing prospects for regenerative medicine.

• Elobixibat Hydrate: Optimizing IBAT Inhibitor Workflows in G

  2026-05-12

  Elobixibat hydrate empowers GI and metabolic research with selective IBAT inhibition, enabling reproducible modeling of chronic idiopathic constipation and metabolic modulation. This article details best-practice workflows, advanced applications, and troubleshooting strategies for maximizing data quality and translational insight.

• Plerixafor (AMD3100): Precision CXCR4 Inhibition for Transla

  2026-05-12

  Explore how Plerixafor (AMD3100) enables precise CXCR4 inhibition in cancer metastasis and hematopoietic stem cell mobilization research. This in-depth article delivers new insights for advanced assay design and translational strategies.

• Capsaicin (C6366): Data-Driven Solutions for Cell Assays

  2026-05-11

  This article addresses five real-world laboratory scenarios where reproducibility, assay design, and data interpretation are challenged in cell viability, proliferation, and cytotoxicity studies. It details how Capsaicin (SKU C6366) from APExBIO delivers reliable, quantitative solutions—backed by mechanistic and protocol evidence—across pain, inflammation, and cancer research models.

• A1 vs. Plerixafor: Advancing CXCR4 Inhibition in Colorectal

  2026-05-11

  Khorramdelazad et al. present A1, a novel fluorinated CXCR4 inhibitor, and demonstrate its superior anti-tumor efficacy over AMD3100 (Plerixafor) in preclinical colorectal cancer models. Their work highlights distinct molecular, cellular, and in vivo advantages of A1 and offers new directions for targeting the CXCL12/CXCR4 axis in cancer research.

• Zolmitriptan as a 5-HT1B Receptor Agonist: Advanced Workflow

  2026-05-10

  Unlock reproducible migraine research with Zolmitriptan—a selective 5-HT1B receptor agonist from APExBIO. This guide details practical protocol enhancements, solubility solutions, and troubleshooting tips, empowering researchers to achieve robust, high-fidelity results in serotonin receptor pharmacology.

• Strategic Use of VX-765 for Translational Inflammation Resea

  2026-05-09

  This thought-leadership article explores the mechanistic and translational impact of VX-765, a potent oral caspase-1 inhibitor, in dissecting inflammatory and cell death pathways. By integrating mechanistic insight, protocol guidance, and competitive context, it offers translational researchers evidence-based strategies for deploying VX-765 in inflammation, autoimmunity, and infectious disease models.

• Locus Coeruleus–Thalamic Circuitry in Pain and Attention Def

  2026-05-08

  This study uncovers a direct pathway from the locus coeruleus to the thalamic reticular nucleus that modulates both chronic pain and attention deficit-like behaviors in mice. By using chemogenetic and optogenetic approaches, the authors reveal a mechanistic link between neural circuit plasticity and comorbid cognitive impairment, offering new insights for targeted intervention strategies.

• CKI 7 dihydrochloride: Precision Casein Kinase 1 Inhibitor W

  2026-05-08

  CKI 7 dihydrochloride empowers researchers to dissect CK1-dependent signaling with unmatched specificity, fueling high-impact cancer biology and circadian rhythm research. Its robust selectivity and purity, backed by APExBIO, streamline both protocol optimization and troubleshooting for advanced cellular assays.

• AI-Driven Identification of Senolytics: Insights for mTOR Re

  2026-05-07

  This article reviews a recent study leveraging machine learning to discover novel senolytic compounds, highlighting methodological advances and the impact on senescence-targeted drug discovery. The findings demonstrate the potential of AI to efficiently identify candidate molecules for eliminating senescent cells, paving the way for new strategies in aging and cancer research.

• Promethazine HCl: Empowering Host-Directed Immunology Resear

  2026-05-07

  Promethazine HCl is transforming inflammation and infection research by enabling precise modulation of histaminergic signaling and macrophage antibacterial activity. Its role in inducing ROS and autophagy positions it as a critical tool for next-generation host-directed therapeutic studies. Discover optimized protocols, troubleshooting strategies, and the latest insights from APExBIO’s trusted offering.

• IgSF6 Deficiency Boosts Macrophage Antibacterial Function vi

  2026-05-06

  This study identifies IgSF6 as an ER-localized immunoglobulin that modulates endoplasmic reticulum (ER) stress and inflammatory responses in intestinal macrophages. The findings reveal that IgSF6 deficiency enhances antibacterial activity but increases vulnerability to colitis, highlighting a key regulatory axis for gut immune homeostasis and inflammation.

• Novel Fluorinated CXCR4 Inhibitor A1 Outperforms AMD3100 in

  2026-05-06

  Khorramdelazad et al. present A1, a fluorinated CXCR4 inhibitor, demonstrating superior tumor suppression and immune modulation compared to AMD3100 in colorectal cancer models. The study's integrative approach highlights A1's potential to redefine CXCL12/CXCR4-targeted therapy and provides benchmarks for preclinical drug development.

• Oleanolic Acid: Dual-Loaded Liposomes & iNOS Induction Insig

  2026-05-05

  Discover how Oleanolic acid empowers dual-loaded liposome workflows for advanced antiviral and immune modulation research. This article details stepwise protocols, troubleshooting, and the latest encapsulation efficiency innovations, translating bench research into robust, reproducible results.

15276 records 1/1019 page Next 12345 下5页 Last page